Global Crude Heparin Market Professional Survey by Types, Applications, and Players, with Regional Growth Rate Analysis and Development Situation, from 2023 to 2028

SKU ID : Maia-24572035

No. of pages : 115

Publishing Date : 03-Aug-2023

According to the latest research, the global Crude Heparin market size was valued at USD 2052.56 million in 2022 and is expected to expand at a CAGR of 5.13% during the forecast period, reaching USD 2771.13 million by 2028.

The crude heparin is mainly extracted from the intestinal mucosa of healthy pigs. Because it contains a large amount of impurity proteins, impurity nucleic acids, microorganisms, etc., it needs to be extracted and separated by physical and chemical means. It is the main raw material of heparin APIs.

COVID-19's Impact On Crude Oil and Refined Products
On March 9, oil prices plummeted 24%, the lowest price this year. After the failure of the OPEC transaction triggered a price war, oil prices fell to a low point. The outbreak of Covid-19 and the growing severity of overproduction of oil have caused the global crude oil market to sink into a low point.

The Covid-19 pandemic has made the demand outlook of the existing market very optimistic. The reason for the sharp drop in oil prices is the decrease in demand from the world 's major consumer countries. For example, North America, Europe, China, Japan, South Korea, South America, and now even India and Southeast. The spread of the virus will deal a heavy blow to its industry and supply chain, and affect oil demand in these areas.

Consumers may be satisfied with lower gasoline prices in a short period of time. Lower crude oil prices lower the cost of production of related basic chemicals. However, this may not be enough to offset the decline in demand for more chemical end-use products.

Market Opportunities and Drivers
The demand for downstream preparations is the main driving force for the steady development of the crude heparin industry. Heparin drugs are one of the most widely used and effective anticoagulant and antithrombotic drugs in clinical applications. Heparin drugs occupy an important position in the market of antithrombotic drugs. The increasing global aging, the growing size of the obese population and the rapid development of the emerging pharmaceutical market will drive the continued increase in the global heparin market demand. The heparin market with strong anticoagulant and antithrombotic capabilities has good development potential. The scale of heparin drugs reached US$12.58 billion in 2015, and the CAGR for 2006-2015 was about 11%. The use of developed countries such as Europe and the United States has grown steadily. Emerging markets have seen strong growth momentum due to the low drug penetration rate.

Market Challenges
Upstream raw material supply fluctuation risk

After industry competition over the past five years, a large number of small and medium-sized enterprises have withdrawn from the industry. In the future, industry competition will enter the field of refined competition, which requires major players in the industry to invest more in technology research and development, energy conservation and environmental protection investment, cost control, and marketing expansion to win more industry status for themselves.

Region Overview:
Asia Pacific had the highest growth rate of all regions.

Company Overview:
Fengrun Biological Technology Co., Ltd. is one of the major players operating in the Crude Heparin market, holding a share of 10.07% in 2020.Founded in April 2009, Fengrun Biotechnology Co., Ltd. is a large professional processing enterprise engaged in natural pork casings and crude heparin sodium. There are more than 1,000 employees, more than 300 professional technicians, more than 200 college graduates and above, with comprehensive strength. The company was listed in the National SME Stock Transfer System Co., Ltd. in April 2017.

Luohe Huisheng Bio-tech Co.,Ltd.
The company is mainly engaged in the processing and sales of pork casings (salted pork casings) and its ancillary products; extraction and sales of pharmaceutical intermediates (heparin sodium); research and development (non-development) of new products.

Segmentation Overview:
Among different product types, Pig Intestine Mucosa Heparin segment is anticipated to contribute the largest market share in 2027.

Application Overview:
By application, the External Sales segment occupied the biggest share from 2017 to 2022.

This report elaborates on the market size, market characteristics, and market growth of the Crude Heparin industry between the year 2018 to 2028, and breaks down according to the product type, downstream application, and consumption area of Crude Heparin. The report also introduces players in the industry from the perspective of the value chain and looks into the leading companies.

Key Points this Global Crude Heparin Market Report Include:
Market Size Estimates: Crude Heparin market size estimation in terms of revenue and sales from 2018-2028
Market Dynamic and Trends: Crude Heparin market drivers, restraints, opportunities, and challenges
Macro-economy and Regional Conflict: Influence of global inflation and Russia & Ukraine War on the Crude Heparin market
Segment Market Analysis: Crude Heparin market revenue and sales by type and by application from 2018-2028
Regional Market Analysis: Crude Heparin market situations and prospects in major and top regions and countries
Crude Heparin Market

Competitive Landscape

and Major Players: Analysis of 10-15 leading market players, sales, price, revenue, gross, gross margin, product/service profile and recent development/updates, etc.
Crude Heparin Industry Chain: Crude Heparin market raw materials & suppliers, manufacturing process, distributors by region, downstream customers
Crude Heparin Industry News, Policies by regions
Crude Heparin Industry Porters Five Forces Analysis

Key players in the global Crude Heparin market are covered in Chapter 2:
Changzhou Qianhong Biopharma Co., Ltd.
Hepac B.V.
Fengrun Biological Technology Co., Ltd.
Aspen Pharmacare Holdings Limited
Luohe Huisheng Bio-tech Co., Ltd.
Jiangsu Wanli Biotechnology Co., Ltd.
Shenzhen Hepalink Pharmaceutical Group Co., Ltd.
Huaian MDC Pharmaceutical Co., Ltd.
Anhui Jinxin Biology Technology Co., Ltd.
Hubei Wurui Bio-Engineering Co.,Ltd.
Hebei Changshan Biochemical Pharmaceutical Co., Ltd.

In Chapter 6 and Chapter 9, on the basis of types, the Crude Heparin market from 2018 to 2028 is primarily split into:
Pig Intestine Mucosa Heparin
Bovine Heparin
Others

In Chapter 7 and Chapter 10, on the basis of applications, the Crude Heparin market from 2018 to 2028 covers:
Internal Sales
External Sales

Geographically, the detailed analysis of consumption, revenue, market share and growth rate of the following regions from 2018 to 2028 are covered in Chapter 8 and Chapter 11:
United States
Europe
China
Japan
India
Southeast Asia
Latin America
Middle East and Africa
Others

In summary, this report relies on sources from both primary and secondary, combines comprehensive quantitative analysis with detailed qualitative analysis, and pictures the market from a macro overview to micro granular segment aspects. Whatever your role in this industry value chain is, you should benefit from this report with no doubt.

Chapter Outline
This report consists of 12 chapters. Below is a brief guideline to help you quickly grasp the main contents of each chapter:

Chapter 1 first introduces the product overview, market scope, product classification, application, and regional division, and then summarizes the global Crude Heparin market size in terms of revenue, sales volume, and average price.

Chapter 2 analyzes the main companies in the Crude Heparin industry, including their main businesses, products/services, sales, prices, revenue, gross profit margin, and the latest developments/updates.

Chapter 3 is an analysis of the competitive environment of Crude Heparin market participants. This mainly includes the revenue, sales, market share, and average price of the top players, along with the market concentration ratio in 2022 and the players' M&A and expansion in recent years.

Chapter 4 is an analysis of the Crude Heparin industrial chain, including raw material analysis, manufacturing cost structure, distributors, and major downstream buyers.

Chapter 5 focuses on Crude Heparin market dynamics and marketing strategy analysis, which include opportunities, challenges, industry development trends under inflation, industry news and policies analyzed by region, Porter's Five Forces analysis, as well as direct and indirect marketing, and the development trends of marketing channels.

Chapters 6-8 have segmented the Crude Heparin market by type, application, and region, with a focus on sales and value from 2018 to 2023 from both vertical and horizontal perspectives.

Chapters 9-11 provide detailed Crude Heparin market forecast data for 2023-2028, broken down by type and application, region, and major countries to help understand future growth trends.

Chapter 12 concludes with an explanation of the data sources and research methods. Verify and analyze through preliminary research to obtain final quantitative and qualitative data.

Years considered for this report:


Historical Years:

2018-2022

Base Year:

2022

Estimated Year:

2023

Forecast Period:

2023-2028

Frequently Asked Questions



This market study covers the global and regional market with an in-depth analysis of the overall growth prospects...
  • By product type
  • By End User/Applications
  • By Technology
  • By Region
The report provides a detailed evaluation of the market by highlighting information on different aspects including drivers, restraints...
market Reports market Reports